Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Mortensen (Farmington, United States of America), A. Anzueto (San Antonio, United States of America). Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia. 2639

Member's Comments

No comment yet.

Related content which might interest you: Association of doxycycline and mortality in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Statin therapy and reduced risk of pneumonia in elderly patients with diabetes Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006 Obesity and outcomes in patients hospitalized for pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012 Impact of obesity on outcomes for patients hospitalised with pneumonia Source: Eur Respir J 2013; 41: 929-934 Year: 2013 Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia Source: ERJ Open Res, 5 (4) 00223-2018; 10.1183/23120541.00223-2018 Year: 2019 Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Admission hyperglycaemia is associated with increased risk of diabetes mellitus following hospitalisation with community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Prevalence and impact of Diabetes mellitus (DM) among hospitalized community-acquired pneumonia (CAP) patients Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Association of dyspnoea, mortality and resource use in hospitalised patients Source: Eur Respir J, 58 (3) 1902107; 10.1183/13993003.02107-2019 Year: 2021 Particularities of pneumonia in diabetes patients. Source: Virtual Congress 2021 – Pneumonia Year: 2021 Impact of diabetes in patients admitted with acute exacerbation of COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Risk of pneumonia or death in COPD outpatients treated with different lengths of corticosteroids Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Impact of diabetes mellitus on microbiological profiles of patients with community-acquired pneumonia in a central hospital Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Hyperglycemia and diabetes mellitus as mortality risk factors in 600 COVID-19 Romanian patients Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021 30-days mortality in patients admitted with COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012